Contemporary OB/GYN is pleased to announce the addition of new members to its distinguished editorial board.
Yalda Afshar, MD, PhD
Dr. Afshar is an assistant professor in the division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, at the University of California, Los Angeles.
“It is such an honor to join a team working tirelessly to disseminate evidence-based best practices to a diverse readership with a simple goal – taking excellent care of the patients in front of us!”
Christine Isaacs, MD
Dr. Isaacs is a general ob/gyn, professor, and Academic Specialist Division Chief at the Virginia Commonwealth University School of Medicine in Richmond, Va. She also is the medical director of Midwifery Services there.
"I'm excited for the opportunity to reflect on the many advancements in our field, to learn from the wisdom of inspirational colleagues, and to contribute to the well-vetted and practical guidance that that supports us as busy clinicians!"
Laura Riley, MD
Dr. Riley is chair of Obstetrics and Gynecology at Weill Cornell Medicine and Obstetrician and Gynecologist-in-Chief at New York Presbyterian Hospital in New York City.
“I am excited to join the editorial board because I have always found the articles in Contemporary OB/GYN to be timely, accurate, and relevant to current practice- always a great resource.”
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More